Vanda Pharmaceuticals Inc

NASDAQ:VNDA   12:16:47 PM EDT
9.93
+0.49 (+5.19%)
Products

Vanda Pharmaceuticals Announces Notice Of Opportunity For An FDA Hearing On The SNDA

Published: 09/07/2022 22:46 GMT
Vanda Pharmaceuticals Inc (VNDA) - Vanda Pharmaceuticals Announces Notice of Opportunity for an FDA Hearing on the Snda for Hetlioz® in Jet Lag Disorder.